Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Royal Biotek
Düsseldorf, Germanyroyalbiotech.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Royal Biotech is a global medical technology company specializing in the development and manufacturing of advanced diagnostic systems and point-of-care testing (POCT) solutions. The company provides a wide range of products including rapid diagnostic kits for infectious diseases, food safety testing, and environmental monitoring tools. Their core technology focuses on biosensors and automated diagnostic platforms designed for high sensitivity and ease of use in clinical and field settings. Royal Biotech serves healthcare providers, laboratories, and industrial clients worldwide with a focus on improving public health through rapid detection.
- Therapeutic areas
- Infectious DiseasesOther
- Modalities
- Diagnostic kitPoint-of-care testingBiosensor
- Industry
- Protein Biomarker Diagnostics
Beyond the preview
Go deeper on Royal Biotek.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Royal Biotek.